Hemodialysis

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

High, Low PTH Raises Hypercalcemia Risk

Jody A. Charnow May 13, 2012

NATIONAL HARBOR, Md.—Low and high levels of parathyroid hormone (PTH) are associated with hypercalcemia, according to a study of 106,760 hemodialysis patients presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

Peginesatide Requirements Do Not Differ By Race

Jody A. Charnow May 13, 2012

NATIONAL HARBOR, Md.—Black hemodialysis (HD) patients with anemia require relatively more epoetin than their non-black counterparts to achieve similar hemoglobin (Hb) levels, but blacks and non-blacks required similar peginesatide doses, according to findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Labs May Vary in iPTH Measurements

Jody A. Charnow May 12, 2012

NATIONAL HARBOR, Md.—Laboratories can differ in their measurements of intact parathyroid hormone (iPTH) levels, resulting in varying treatment approaches for hemodialysis (HD) patients depending on the iPTH assay used, researchers reported at the National Kidney Foundation Spring Clinical Meetings.

PCa Patients on HD Would Benefit from Early Kidney Transplantation

Jody A. Charnow May 12, 2012

NATIONAL HARBOR, Md.—Hemodialysis (HD) patients awaiting a kidney transplant must have a two-year cancer-free period immediately preceding transplantation.

Higher Alkaline Phosphatase Raises Death Risk in HD Patients

Jody A. Charnow May 12, 2012

NATIONAL HARBOR, Md.—Elevated levels of serum alkaline phosphatase are associated with decreased long-term survival among hemodialysis (HD) patients, data presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

Calcitriol as Effective as Vitamin D Analogues, but Cheaper

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Oral calcitriol is as effective as vitamin D analogues for treating secondary hyperparathyroidism (SHPT) in hemodialysis patients but is more cost effective, according to a study presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Novel Iron-Based Phosphate Binder Effective, Well-Tolerated

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—An investigational iron-based phosphate binder is effective and well tolerated in hemodialysis (HD) patients with hyperphosphatemia, according to data presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Study: Phosphate Binder Noncompliance Underreported

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Dialysis patient underreporting of noncompliance with phosphate binder therapy may contribute to poor phosphorus control, investigators reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Black Home HD Patients More Likely to Return to In-Center HD

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Black home hemodialysis (HD) patients are more likely than their white counterparts to return to in-center HD, according to data presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

X-Rays Unreliable for Diagnosing Pneumonia in HD Patients

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Chest X-rays are unreliable for diagnosing pneumonia in hemodialysis (HD) patients, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Hemoglobin Trends Change in Wake of Bundling

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Researchers have found that hemoglobin levels in dialysis patients have changed since implementation of the bundled payment system for dialysis services in January 2011, according to a report presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

IV Iron Drugs Not Equal in Hemoglobin Response

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—In a recently completed clinical trial, treatment with ferumoxytol resulted in a greater hemoglobin (Hb) response than iron sucrose in hemodialysis (HD) patients with anemia and non-dialysis patients with severe anemia, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Higher CV Event Rate Linked to Low Hb in HD Patients

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Hemodialysis (HD) patients receiving either epoetin or peginesatide who achieve low hemoglobin (Hb) levels have an increased rate of cardiovascular (CV) events, according to new data presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Implantable Artificial Kidney Advances

John Schieszer May 08, 2012

An implantable artificial kidney is moving closer toward reality.

Early Dialysis Starts Associated with Worse Outcomes

Rosemary Frei, MSc May 07, 2012

This approach is associated with an increased likelihood of withdrawal from treatment, study finds.

Estradiol Levels Affect Death Risk Among Women on HD

Jody A. Charnow May 02, 2012

High and low serum estradiol levels in women on hemodialysis (HD) are associated with increased overall and cardiovascular mortality, according to researchers.

Hospitalization Risk for Infections Higher with PD

Rosemary Frei, MSc April 30, 2012

ST. JOHN'S, NEWFOUNDLAND—Patients on peritoneal dialysis (PD) are at 51% higher risk of being hospitalized for infections than those receiving hemodialysis (HD), according to findings presented at the Canadian Society of Nephrology annual meeting.

Kidney Disease Leaders Recommend Ways to Expand Home Dialysis Use

Stephan Cho April 30, 2012

Leaders in the dialysis community have released a report that outlines key findings and recommendations for better utilization of home dialysis as an alternative to in-center treatment.

Safest Hemodialysis Vascular Access Options Unclear

Rosemary Frei, MSc April 28, 2012

ST. JOHN'S, NEWFOUNDLAND—Central venous catheters (CVCs) are associated with the highest mortality risk among hemodialysis (HD) vascular access options, according to a systematic literature review presented at the Canadian Society of Nephrology's 2012 annual meeting. Arteriovenous grafts confer the second-highest risk for mortality, followed by native arteriovenous fistulas (AVFs).

Antimicrobial Locks in HD Catheters May Have a Down Side

Jody A. Charnow April 20, 2012

Antimicrobial locks (AML) decrease the incidence of catheter-related bloodstream infections in hemodialysis (HD) patients, but they may result in the emergence of problematic pathogens, according to British investigators.

Use of a Lifeline Graft in the A-V Shunt Model

Protein Intake, Nutrition and Cardiovascular Diseases in Stage V CKD

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study (LANDMARK)

Newsletters

Latest News
Latest CME
Ongoing Clinical Trials
Conference Highlights
Expert Q&A

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

Your Practice

The move from ICD-9-CM to ICD-10 is enough to strike fear into the hearts of physicians and staff alike. Making the leap from 14,000 codes to almost 69,000, topped with the huge cost to make that change, is understandably daunting.

Read more on
Coping with ICD-10

Have any practice management topics that you'd like us to cover?
Let us know.